Therapy of gallstone disease: What it was, what it is, what it will be

doi:10.4292/wjgpt.v3.i2.7

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 3, Issue 2

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (20118)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-4) series.

Item

Count

PDF

1186

HTML

17890

Figures (1-5)

756

Tables (1-4)

286

Sum=20118

Apr 6, 2012 (publication date) through Feb 6, 2025

Times Cited of This Article

Times Cited (76)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Pharmacology and Therapeutics

ISSN

2150-5349

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastrointest Pharmacol Ther. Apr 6, 2012; 3(2): 7-20
Published online Apr 6, 2012. doi: 10.4292/wjgpt.v3.i2.7

Full Size Figure Download Figure

Figure 3 Chemical formula of bile acids used for oral litholysis of small, radiotransparent, cholesterol-enriched gallstones in a functioning gallbladder with a patent cystic duct of patients with symptomatic gallstones. CDCA: Chenodeoxycholic acid; UDCA: Ursodeoxycholic acid; TUDCA: Tauroursodeoxycholic acid.

Citation: Portincasa P, Ciaula AD, Bonfrate L, Wang DQ. Therapy of gallstone disease: What it was, what it is, what it will be. World J Gastrointest Pharmacol Ther 2012; 3(2): 7-20
URL: https://www.wjgnet.com/2150-5349/full/v3/i2/7.htm
DOI: https://dx.doi.org/10.4292/wjgpt.v3.i2.7